Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-27 @ 10:39 PM
Study NCT ID:
NCT01145495
Status:
COMPLETED
Last Update Posted:
2023-06-27
First Post:
2010-06-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2012-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-15
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-15
First Submit QC Date:
None
Study First Post Date:
2010-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-06
Results First Submit QC Date:
None
Results First Post Date:
2014-02-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-07
Last Update Post Date:
2023-06-27
Last Update Post Date Type:
ACTUAL